Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Weiye Li MD, PhD
Weiye Li MD, PhD Advisory Board
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO Advisory Board
Paul Freeman OD, FAAO, FOVDR
Paul B. Freeman OD, FAAO, FOVDR Editor-in-Chief
See All Experts
story of the week
Published in Eye Care and
1 other channel

Journal Scan / Research · June 11, 2019

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss in Center-Involved DME

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

JAMA: The Journal of the American Medical Association
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
JAMA 2019 May 29;321(19)1880-1894, CW Baker, AR Glassman, WT Beaulieu, AN Antoszyk, DJ Browning, KV Chalam, S Grover, LM Jampol, CD Jhaveri, M Melia, CR Stockdale, DF Martin, JK Sun

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated